🇺🇸 FDA
Patent

US 8211422

Chimeric receptor genes and cells transformed therewith

granted A61KA61K38/00A61K40/11

Quick answer

US patent 8211422 (Chimeric receptor genes and cells transformed therewith) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jul 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K38/00, A61K40/11, A61K40/32, A61K40/42